Abbott plans to spin out its nutrition business

Abbott plans to spin out its nutrition business is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Ricky Zipp · 2026-10-21

Abbott, which also cut its 2026 sales growth guidance, said company sales will total $42 billion following the separation.

Source: MedTech Dive